Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The J.M Smucker Company | SJM | Jan 17, 2025 | 102.14 | -0.39 |
The Joint | JYNT | Jan 17, 2025 | 11.19 | +1.73 |
The Marygold Companies | MGLD | Jan 17, 2025 | 1.71 | -1.16 |
The ODP | ODP | Jan 17, 2025 | 24.78 | +1.72 |
The OLB Group | OLB | Jan 17, 2025 | 1.93 | +4.10 |
The Oncology Institute | TOI | Jan 17, 2025 | 0.55 | +13.40 |
The ONE Group Hospitality | STKS | Jan 17, 2025 | 3.32 | -1.19 |
The Pennant Group | PNTG | Jan 17, 2025 | 27.46 | +0.88 |
The Real Brokerage | REAX | Jan 17, 2025 | 4.54 | +2.71 |
The Real Estate Select Sector SPDR Fund | XLRE | Jan 17, 2025 | 41.08 | -0.02 |
The RealReal | REAL | Jan 17, 2025 | 9.52 | +0.74 |
The RMR Group A | RMR | Jan 17, 2025 | 19.76 | +0.20 |
The Shyft Group | SHYF | Jan 17, 2025 | 12.42 | +0.73 |
The Trade Desk A | TTD | Jan 17, 2025 | 124.42 | +2.96 |
The9 ADR | NCTY | Jan 17, 2025 | 16.77 | +5.27 |
TherapeuticsMD | TXMD | Jan 17, 2025 | 1.06 | +1.92 |
Theratechnologies | THTX | Jan 17, 2025 | 1.72 | -0.58 |
Theravance Biopharma | TBPH | Jan 17, 2025 | 8.58 | +1.66 |
Theriva Biologics | TOVX | Jan 17, 2025 | 1.48 | +3.50 |
Thermo Fisher Scientific | TMO | Jan 17, 2025 | 559.65 | -0.37 |
Thermon Group | THR | Jan 17, 2025 | 29.34 | +0.58 |
Third Coast Bancshares | TCBX | Jan 17, 2025 | 33.10 | +1.04 |
Third Harmonic | THRD | Jan 17, 2025 | 5.79 | +1.94 |
Thomson Reuters | TRI | Jan 17, 2025 | 159.25 | +0.70 |
Thor Industries | THO | Jan 17, 2025 | 101.73 | -2.14 |
Thornburg Income Builder Opportunities Fund | TBLD | Jan 17, 2025 | 16.78 | +0.48 |
ThredUp A | TDUP | Jan 17, 2025 | 2.26 | +4.15 |
Thryv | THRY | Jan 17, 2025 | 15.79 | -1.44 |
Thumzup Media | TZUP | Jan 17, 2025 | 3.63 | 0.00 |
Thunder Bridge Capital Partners IV SPAC A | THCP | Jan 17, 2025 | 12.24 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.